Alessandra Cesano

Alessandra Cesano

Company: ESSA Pharma

Job title: Chief Medical Officer

Seminars:

Evidence Enabling Informed Biomarker Strategy Decision Making 3:50 pm

Read more

day: Day One

Chair’s Closing Remark & End of Day 1 6:00 pm

Read more

day: Day One

Panel Discussion: How to Know When a CDx & a Predictive Biomarker is Needed for a Drug 4:00 pm

Discussing criteria determining which drugs to progress for CDx selection to inform clinical strategy and investment plan Changing requirements to implement a diagnostic in the early phase clinical trial Vs what’s needed for later approval Engaging different arms of the business, to build trust for CDx development Pre-empting bottlenecks in Dx development to de-risk investmentRead more

day: Day One

Defining Your Patient Population

1:35 pm

Read more

day: Track B - Day 1 PM

Early Biomarker Decision-Making for Time-Efficient Clinical Planning 10:05 am

Read more

day: Track B - Day 1 AM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.